Literature DB >> 25267638

Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner binding and substrate delivery.

Karl R Schmitz1, Daniel W Carney2, Jason K Sello2, Robert T Sauer3.   

Abstract

Caseinolytic peptidase P (ClpP), a double-ring peptidase with 14 subunits, collaborates with ATPases associated with diverse activities (AAA+) partners to execute ATP-dependent protein degradation. Although many ClpP enzymes self-assemble into catalytically active homo-tetradecamers able to cleave small peptides, the Mycobacterium tuberculosis enzyme consists of discrete ClpP1 and ClpP2 heptamers that require a AAA+ partner and protein-substrate delivery or a peptide agonist to stabilize assembly of the active tetradecamer. Here, we show that cyclic acyldepsipeptides (ADEPs) and agonist peptides synergistically activate ClpP1P2 by mimicking AAA+ partners and substrates, respectively, and determine the structure of the activated complex. Our studies establish the basis of heteromeric ClpP1P2 assembly and function, reveal tight coupling between the conformations of each ring, show that ADEPs bind only to one ring but appear to open the axial pores of both rings, provide a foundation for rational drug development, and suggest strategies for studying the roles of individual ClpP1 and ClpP2 rings in Clp-family proteolysis.

Entities:  

Keywords:  AAA+ proteases; allosteric coupling; pathogen drug target

Mesh:

Substances:

Year:  2014        PMID: 25267638      PMCID: PMC4217457          DOI: 10.1073/pnas.1417120111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  Communication between ClpX and ClpP during substrate processing and degradation.

Authors:  Shilpa A Joshi; Greg L Hersch; Tania A Baker; Robert T Sauer
Journal:  Nat Struct Mol Biol       Date:  2004-04-04       Impact factor: 15.369

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

4.  Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.

Authors:  Heike Brötz-Oesterhelt; Dieter Beyer; Hein-Peter Kroll; Rainer Endermann; Christoph Ladel; Werner Schroeder; Berthold Hinzen; Siegfried Raddatz; Holger Paulsen; Kerstin Henninger; Julia E Bandow; Hans-Georg Sahl; Harald Labischinski
Journal:  Nat Med       Date:  2005-10-02       Impact factor: 53.440

5.  Crystal structure at 1.9A of E. coli ClpP with a peptide covalently bound at the active site.

Authors:  Agnieszka Szyk; Michael R Maurizi
Journal:  J Struct Biol       Date:  2006-04-21       Impact factor: 2.867

6.  Molecular determinants of complex formation between Clp/Hsp100 ATPases and the ClpP peptidase.

Authors:  Y I Kim; I Levchenko; K Fraczkowska; R V Woodruff; R T Sauer; T A Baker
Journal:  Nat Struct Biol       Date:  2001-03

7.  Functional domains of the ClpA and ClpX molecular chaperones identified by limited proteolysis and deletion analysis.

Authors:  S K Singh; J Rozycki; J Ortega; T Ishikawa; J Lo; A C Steven; M R Maurizi
Journal:  J Biol Chem       Date:  2001-05-09       Impact factor: 5.157

8.  The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes.

Authors:  O Gaillot; E Pellegrini; S Bregenholt; S Nair; P Berche
Journal:  Mol Microbiol       Date:  2000-03       Impact factor: 3.501

9.  The ClpP protease of Streptococcus pneumoniae modulates virulence gene expression and protects against fatal pneumococcal challenge.

Authors:  Hyog-Young Kwon; A David Ogunniyi; Moo-Hyun Choi; Suhk-Neung Pyo; Dong-Kwon Rhee; James C Paton
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  Genes required for mycobacterial growth defined by high density mutagenesis.

Authors:  Christopher M Sassetti; Dana H Boyd; Eric J Rubin
Journal:  Mol Microbiol       Date:  2003-04       Impact factor: 3.501

View more
  35 in total

1.  Initial Characterization of the Two ClpP Paralogs of Chlamydia trachomatis Suggests Unique Functionality for Each.

Authors:  Nicholas A Wood; Krystal Y Chung; Amanda M Blocker; Nathalia Rodrigues de Almeida; Martin Conda-Sheridan; Derek J Fisher; Scot P Ouellette
Journal:  J Bacteriol       Date:  2018-12-20       Impact factor: 3.490

2.  Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease.

Authors:  Kirsten Famulla; Peter Sass; Imran Malik; Tatos Akopian; Olga Kandror; Marina Alber; Berthold Hinzen; Helga Ruebsamen-Schaeff; Rainer Kalscheuer; Alfred L Goldberg; Heike Brötz-Oesterhelt
Journal:  Mol Microbiol       Date:  2016-04-01       Impact factor: 3.501

3.  Structure and activation of a heteromeric protease complex.

Authors:  Jing Liu; Peter Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-20       Impact factor: 11.205

Review 4.  Bacterial proteases, untapped antimicrobial drug targets.

Authors:  Elizabeth Culp; Gerard D Wright
Journal:  J Antibiot (Tokyo)       Date:  2016-11-30       Impact factor: 2.649

5.  Two Isoforms of Clp Peptidase in Pseudomonas aeruginosa Control Distinct Aspects of Cellular Physiology.

Authors:  Branwen M Hall; Elena B M Breidenstein; César de la Fuente-Núñez; Fany Reffuveille; Gina D Mawla; Robert E W Hancock; Tania A Baker
Journal:  J Bacteriol       Date:  2017-01-12       Impact factor: 3.490

6.  Structure Determination of Mycobacterium tuberculosis Serine Protease Hip1 (Rv2224c).

Authors:  Jacqueline L Naffin-Olivos; Andrew Daab; Andre White; Nathan E Goldfarb; Amy C Milne; Dali Liu; Jacqueline Baikovitz; Ben M Dunn; Jyothi Rengarajan; Gregory A Petsko; Dagmar Ringe
Journal:  Biochemistry       Date:  2017-04-07       Impact factor: 3.162

7.  Clostridium difficile ClpP Homologues are Capable of Uncoupled Activity and Exhibit Different Levels of Susceptibility to Acyldepsipeptide Modulation.

Authors:  Nathan P Lavey; Tyler Shadid; Jimmy D Ballard; Adam S Duerfeldt
Journal:  ACS Infect Dis       Date:  2018-11-26       Impact factor: 5.084

8.  Examination of a Structural Model of Peptidomimicry by Cyclic Acyldepsipeptide Antibiotics in Their Interaction with the ClpP Peptidase.

Authors:  Daniel W Carney; Karl R Schmitz; Anthony C Scruse; Robert T Sauer; Jason K Sello
Journal:  Chembiochem       Date:  2015-07-27       Impact factor: 3.164

9.  Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis.

Authors:  Mi Li; Olga Kandror; Tatos Akopian; Poorva Dharkar; Alexander Wlodawer; Michael R Maurizi; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2016-02-08       Impact factor: 5.157

10.  An allosteric switch regulates Mycobacterium tuberculosis ClpP1P2 protease function as established by cryo-EM and methyl-TROSY NMR.

Authors:  Siavash Vahidi; Zev A Ripstein; Jordan B Juravsky; Enrico Rennella; Alfred L Goldberg; Anthony K Mittermaier; John L Rubinstein; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.